| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.1 |